Quest Diagnostics Incorporated (BIT:1QDX)

Market Cap	19.18B +12.7%
Revenue (ttm)	9.78B +11.0%
Net Income	884.65M +14.2%
EPS	7.85 +14.4%
Shares Out	n/a
PE Ratio	21.68
Forward PE	18.01
Dividend	2.10 (1.19%)
Ex-Dividend Date	Apr 2, 2026

Volume	77
Open	176.10
Previous Close	166.50
Day's Range	174.90 - 176.10
52-Week Range	138.70 - 184.70
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 21, 2026

About Quest Diagnostics

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceu...

• Industry: Medical Laboratories
• Founded: 1967
• Employees: 51,500
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1QDX

Financial Performance

In 2025, Quest Diagnostics's revenue was $11.04 billion, an increase of 11.78% compared to the previous year's $9.87 billion. Earnings were $988.00 million, an increase of 14.09%.

Financial numbers in USD

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Jun 17, 2026

Data Sources Report a data error